𝔖 Bobbio Scriptorium
✦   LIBER   ✦

lobaplatin in combination with methotrexate and vinblastine in patients with transitional cell carcinoma of the urinary tract—a pilot phase I/(II) study

✍ Scribed by P. Jung; P. Bachmann; K. Burk; G. Jakse

Book ID
116166479
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
254 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of mitoguazone and vinb
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract
✍ John T. Barrett; Bruno Orofiamma; Janardan D. Khandekar; Paul P. Carbone; Robert 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0

Phase II trial of intermediate dose meth
Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra

Platinum-free combination chemotherapy i
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma : A Phase I/II trial of gemcitabine, paclitaxel, and methotrexate
✍ Primo N. Lara Jr; Frederick J. Meyers; Lisa Y. Law; Nancy A. Dawson; Joan Housto 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND Platinum‐based regimens have improved response rates and survival in patients with advanced transitional cell carcinoma (TCC) of the urothelial tract. However, the toxicities of platinum‐based chemotherapy are considerable. Regimens with reduced toxicity that are applicab

A study of cyclophosphamide, adriamycin,
A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract
✍ Dennis L. Citrin; Tom F. Hogan; Tom E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 2 views

Twenty patients with locally advanced and/or metastatic transitional cell cancer of the urinary tract were treated with cyclophosphamide 500 mg/m2, Adriamycin (doxorubicin) 40 mg/m2 and cis-platinum (CDDP) 40 mg/m2 given every three weeks for 2 cycles, alternating with methotrexate 40 mg/m2 weekly f